Mevalonate Kinase (MVK) Peptid
MVK
Reaktivität: Säugetier
Wirt: Synthetic
BP, WB, IHC
-
- Target Alle MVK Produkte
- MVK (Mevalonate Kinase (MVK))
- Protein-Typ
- Synthetic
- Spezies
- Säugetier
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequenz
- LAVLAFLYLY LSICRKQRAL PSLDIVVWSE LPPGAGLGSS AAYSVCLAAA
- Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of MVK antibody,
Alternative Names: MVK control peptide, MVK antibody Blocking Peptide, Anti-MVK Blocking Peptide, Mevalonate Kinase Blocking Peptide, LRBP Blocking Peptide, MVLK Blocking Peptide - Aufreinigung
- The antibody is affinity-purified from rabbit antiserum by affinity chromatography using epitope-specific phosphopeptide. The antibody against non-phosphopeptide is removed by chromatography using non-phosphopeptide corresponding to the phosphorylation site.
-
-
- Applikationshinweise
- Optimal conditions should be determined by the investigator
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handhabung
- Avoid repeated freeze/thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20 °C long term.
-
- Target
- MVK (Mevalonate Kinase (MVK))
- Hintergrund
- MVK is the peroxisomal enzyme mevalonate kinase. Mevalonate is a key intermediate, and mevalonate kinase a key early enzyme, in isoprenoid and sterol synthesis. Mevalonate kinase deficiency caused by mutation of this gene results in mevalonic aciduria, a disease characterized psychomotor retardation, failure to thrive, hepatosplenomegaly, anemia and recurrent febrile crises. Defects in this gene also cause hyperimmunoglobulinaemia D and periodic fever syndrome, a disorder characterized by recurrent episodes of fever associated with lymphadenopathy, arthralgia, gastrointestinal dismay and skin rash.
- Molekulargewicht
- 42 kDa
-
Sie sind hier:
